Effects of Interleukin-6 on in vitro cell attachment, migration and invasion of human ovarian carcinoma

Anticancer Research

Volumn 17, Issue 1 A, 1997, Pages 337-342

  Obata, Naoko Hasegawa ^a   Tamakoshi, Koji ^a   Shibata, Kiyosumi ^a   Kikkawa, Fumitaka ^a   Tomoda, Yutaka ^a  

^a NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Interleukin 6; Invasion; Ovarian cancer

Indexed keywords

GELATINASE; INTERLEUKIN 6; MATRIGEL; MATRIX METALLOPROTEINASE; TISSUE INHIBITOR OF METALLOPROTEINASE;

ARTICLE; ASCITES FLUID; CANCER INVASION; CELL ADHESION; CELL MIGRATION; CHEMOKINESIS; CHEMOTAXIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; OVARY CARCINOMA; PRIORITY JOURNAL;

CELL ADHESION; CELL MOVEMENT; COLLAGEN; DRUG COMBINATIONS; FEMALE; GELATINASES; GLYCOPROTEINS; HUMANS; INTERLEUKIN-6; LAMININ; NEOPLASM INVASIVENESS; OVARIAN NEOPLASMS; PROTEIN BIOSYNTHESIS; PROTEOGLYCANS; TISSUE INHIBITOR OF METALLOPROTEINASE-2; TISSUE INHIBITOR OF METALLOPROTEINASES;

EID: 0031049172     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. Kishimoto, T: The biology of interleukin-6. Blood 74: 1-10, 1989.
2. Andus T, Geiger T, Hirano T, Northoff H, Ganter U, Bauer J, Kishimoto T and Heinrich PC: Recombinant human B-cell stimulatory factor 2 (BSF-2 / IFNβ2) regulates β-fibrinogen and albumin mRNA levels in Fao-9 cells. FEBS Lett 221: 18-22, 1987.
3. Gauldie J, Richards C, Harnish D, Lansdorp P and Baumann H: Interferon β2 / B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84: 7251-7255, 1987.
4. Miki S, Iwano M, Miki Y, Yamamoto M, Tang B, Yokokawa K, Sonoda T, Hirano T and Kishimoto T: Interleukin-6 (IL-6) functions as in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 250/607-610, 1989.
5. Eustace D, Han X, Gooding R, Rowbottom A, Riches P and Heyderman E: Interleukin-6 (IL-6) functions as an autocrine growth factor in cervical carcinomas in vitro. Gynecol Oncol 50: 15-19, 1993.
6. Wu S, Rodabough K, Martinez-Maza O, Watson JM, Silverstein DS, Boyer CM, Peters WP, Weinbere B, Berek JS and Bast JrRC: Stimulation of ovarian tumor cell proliferation with monocytes products including interleukin-1, interleukin-6, and tumor necrosis factor-A. Am J Obstet Gynecol 166: 997-1007, 1992.
7. Watson JM, Sensitaffar JL, Berek JS and Martinez-Maza O: Constitutive production of interleukin-6 by ovarian cancer cell lines and by primary ovarian tumor cultures. Cancer Res 50: 6959-6965, 1990.
8. Plante M, Rubin SC Wong GY, Federici MG, Finstad CL and Gastl GA: Interleukin-6 level in serum and ascites as a prognostic factor in patients with epithelial ovarian cancer. Cancer 73: 1882-1888, 1994.
9. Scambia G, Testa U, Benedetti Panici P, Foti E, Martucci R, Gadducci A, Perillo A, Facchini V, Peschle C and Mancuso S: Prognostic significance of interleukin 6 serum levels in patients with ovarian cancer. Brit J Cancer 71: 354-356, 1995.
10. Dejana E, Bertocchi F, Bortolami MC, Regonesi A, Tonta A, Breviario, F and Giavazzi R: Interleukin-1 promotes tumor cell adhesion to cultured human endothelial cells. J Clin Invest 82: 1466-1477, 1988.
11. Yanase S, Tsukamoto T and Kumamoto Y: Cytokines modulate in vitro invasiveness of renal cell carcinoma cells through action on the process of cell attachment to endothelial cells. J Urol 153: 844-848, 1995.
12. Tamm I, Kikuchi T, Cardinale I and Krueger JG: Cell-adhesion-disrupting action of interleukin 6 in human ductal breast carcinoma cells. Proc Natl Acad Sci USA 91: 3329-3333, 1994.
13. Stetler-Stevenson WG, Liotta LA and Kleiner JrDE: Extracellular matrix 6: role of matrix metalloproteinases in tumor invasion and metastasis. FASEB J 7: 1434-1441, 1993.
14. Roeb E, Graeve L, Müllberg J, Matern S, and Rose-John S: TIMP-1 protein expression is stimulated by IL-1β and IL-6 in primary rat hepatocytes. FEBS Lett 349: 45-49, 1994.
15. Kordula T, Güttgemann I, Rose-John S, Roeb E, Osthues A, Tschesche H, Koj A, Heinrich P C and Graeve L: Synthesis of tissue inhibitor of metalloproteinase-1 (TIMP-1) in human hepatoma cells (HepG2) : Up-regulation by interleukin-6 and transforming growth factor β1. FEBS Lett 313: 143-147, 1992.
16. Emonard H, Munaut C, Melin M, Lortat-Jacob H and Grimaud J-A: Interleukin-6 does not regulate interstitial collagenase, stromelysin and tissue inhibitor of metalloproteinases synthesis by cultured human fibroblasts. Matrix 12: 471-474, 1992.
17. Imai T, Koike K, Kubo T, Kikuchi T, Amano Y, Takagi M, Okamura, N and Nakahata T: Interleukin-6 supports human megakaryocyte proliferation and differentiation in vitro. Blood 78: 1969-1974, 1991.
18. KS Asano S, Okano A, Ozawa K, Nakahata T, Ishibashi T, Koike K, Kimura H, Tanioka Y, Shibuya A, Hirano T, Kishimoto T, Takaku F and Akiyama Y: In vitro effects of recombinant human interleukin-6 in primates: stimulated production of platelets. Blood 75: 1602-1605, 1990.
19. D'Hondt V, Humblet Y, Guillaume Th, Baatout S, Chatelain C, Berlinre M, Longueville J, Feyens AM, De Greve J, Van Oosterom A, Von Graffenried B, Donnez J and Symann M: Thrombopoietic effects and toxicity of interleukin-6 in patients with ovarian cancer before and after chemotherapy: a multicentric placebo-controlled, randomized phase Ib study. Blood 85: 2347-2353, 1995.
20. Lanfrancone L, Boraschi D, Ghiara P, Falini B, Grignani F, Peri G, Mantovani A and Pelicci PG: Human peritoneal mesothelial cells produce many cytokines (granulocyte colony-stimulating factor [CSF], granulocyte-monocyte-CSF, macrophage-CSF, interleukin-1 [IL-1], and 1L-6) and are activated and stimulated to grow by IL-1. Blood 80: 2835-2842, 1992.